{"id":6006,"date":"2025-06-13T23:19:58","date_gmt":"2025-06-13T23:19:58","guid":{"rendered":"https:\/\/zerospike.org\/?p=6006"},"modified":"2025-06-13T23:20:00","modified_gmt":"2025-06-13T23:20:00","slug":"la-proteina-spike-persiste-nei-pazienti-con-sindrome-vaccinale-di-lunga-durata","status":"publish","type":"post","link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39767757\/","title":{"rendered":"La proteina \u201cSpike\u201d persiste nei pazienti con sindrome vaccinale di lunga durata"},"content":{"rendered":"<p>Rif.: Detection of S1 spike protein in CD16+ monocytes up to 245 days in SARS-CoV- 2-negative post-COVID-19 vaccine syndrome (PCVS) individuals Bruce K. Patterson et al.<br>HUMAN VACCINES &amp; IMMUNOTHERAPEUTICS 2025, VOL. 21, NO. 1, 2494934 https:\/\/doi.org\/10.1080\/21645515.2025.2494934<br>Sintomi come problemi cardiaci, vascolari e neurologici spesso emergono poco dopo la vaccinazione e persistono per mesi o anni. Gli autori hanno dimostrato la persistenza di proteina spike per mesi nei monociti dei pazienti con sintomi rispetto a quelli senza sintomi e un profilo infiammatorio associato alla sindrome post-vaccinale.<\/p>\n\n\n\n<p>Nello spiegare la \u201cPost-acute covid vaccination syndrome\u201d questo articolo si associa bene a quello da noi pubblicato nel dicembre scorso, in cui abbiamo dimostrato la presenza di anticorpi anti-spike e di anticorpi anti-ACE2 nella stessa sindrome: https:\/\/pubmed.ncbi.nlm.nih.gov\/39767757\/<\/p>","protected":false},"excerpt":{"rendered":"<p>Rif.: Detection of S1 spike protein in CD16+ monocytes up to 245 days in SARS-CoV- 2-negative post-COVID-19 vaccine syndrome (PCVS) individuals Bruce K. Patterson et al.HUMAN VACCINES &amp; IMMUNOTHERAPEUTICS 2025, &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/39767757\/\" class=\"more-link\">\u7d9a\u304d\u3092\u8aad\u3080<span class=\"screen-reader-text\"> &#8220;La proteina \u201cSpike\u201d persiste nei pazienti con sindrome vaccinale di lunga durata&#8221;<\/span><\/a><\/p>","protected":false},"author":194,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_eb_attr":"","_price":"","_stock":"","_tribe_ticket_header":"","_tribe_default_ticket_provider":"","_tribe_ticket_capacity":"","_ticket_start_date":"","_ticket_end_date":"","_tribe_ticket_show_description":"","_tribe_ticket_show_not_going":false,"_tribe_ticket_use_global_stock":"","_tribe_ticket_global_stock_level":"","_global_stock_mode":"","_global_stock_cap":"","_tribe_rsvp_for_event":"","_tribe_ticket_going_count":"","_tribe_ticket_not_going_count":"","_tribe_tickets_list":"[]","_tribe_ticket_has_attendee_info_fields":false,"footnotes":""},"categories":[5],"tags":[],"class_list":["post-6006","post","type-post","status-publish","format-standard","hentry","category-it"],"_links":{"self":[{"href":"https:\/\/zerospike.org\/ja\/wp-json\/wp\/v2\/posts\/6006","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/zerospike.org\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/zerospike.org\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/zerospike.org\/ja\/wp-json\/wp\/v2\/users\/194"}],"replies":[{"embeddable":true,"href":"https:\/\/zerospike.org\/ja\/wp-json\/wp\/v2\/comments?post=6006"}],"version-history":[{"count":1,"href":"https:\/\/zerospike.org\/ja\/wp-json\/wp\/v2\/posts\/6006\/revisions"}],"predecessor-version":[{"id":6007,"href":"https:\/\/zerospike.org\/ja\/wp-json\/wp\/v2\/posts\/6006\/revisions\/6007"}],"wp:attachment":[{"href":"https:\/\/zerospike.org\/ja\/wp-json\/wp\/v2\/media?parent=6006"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/zerospike.org\/ja\/wp-json\/wp\/v2\/categories?post=6006"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/zerospike.org\/ja\/wp-json\/wp\/v2\/tags?post=6006"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}